Extracorporeal Membrane Oxygtioenan (ECMO) System Market, By Modality (Arteriovenous, Venoarteial, and Venovenous), By Application (Extracorporeal cardiopulmonary resuscitation, Cardiac, and Respiratory), By Age Group (Neonatal, Pediatric, and Adults), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis, and Forecast till 2029

Extracorporeal Membrane Oxygtioenan (ECMO) System Market accounted for US$ 285.3 million in 2019 and is estimated to be US$ 430.3 million by 2029 and is anticipated to register a CAGR of 4.2%.

Extracorporeal membrane oxygenation system is a device which provides respiratory and cardiac support to the patients suffering from severe respiratory failure. ECMO oxygenates the blood and remove carbon dioxide through extracorporeal gas exchange device. It consists of pump, cannulas, blender, and oxygenator. Nowadays, ECMO has become more consistent with development in equipment. In addition, change in dietary habits and lifestyle is leading to cause various chronic diseases including respiratory and cardiac disease, which in turn, increase the need of extracorporeal membrane oxygenation machine.

COVID-19 Impact on the Market:

With the outbreak of the COVID-19, various businesses are at the forefront to combat this pandemic. The pandemic has hindered the industrial supply chain and also disrupted the production segment. Government across the countries has imposed strict lockdown to limit the spread of disease. However, increasing investments by prominent players and other industries has created growth opportunities, during this chaotic situation, to fulfill the demand of suppliers. This report will quantify the impact of this pandemic on the extracorporeal membrane oxygenation (ECMO) system market.

According to World Health Organization (WHO), nearly 17.7 million deaths i.e. around 31% of total global deaths was due to cardiovascular disease in 2015. In addition, according to European Heart Network AISBL, around 3.9 million and over 1.8 million deaths occurs every year in Europe and European Union respectively, which estimated around 45% of all deaths in European Union. Thus, increasing prevalence of cardiac and respiratory diseases are driving growth of the global extracorporeal membrane oxygenation (ECMO) system. Currently, the world is experiencing the COVID-19 pandemic. This infection leads to acute & severe respiratory disorders, multiple organ failure, pneumonia, and even death in severe cases.

Advent of innovative products and significant investments by key players

Getinge, Medtronic, LivaNova, Alung Technologies, Terumo, and Abbott are some of the notable industry players in the market. New product launches, strategic collaboration and partnerships, merger and acquisitions, are major strategies followed by these companies. Introduction of innovative products and significant investment towards research and development by the companies has accelerated the competition in the market. For instance, in September 2017, CytoSorbents Corporation launched the CytoSorb Therapeutic ECMO kit in Austria. This kit enables CytoSorb blood purification cartridge with innovative tubing connector set that allows easy integration in most of the commercial ECMO systems available in the market.

On the flip side, high cost and lack of skilled professionals is a challenge to the market. In addition, complications related with the target market such as infections, bleeding, and technical failures might hamper growth of the global market.

The global extracorporeal membrane oxygenation (ECMO) system market is segmented based on the modality, application, age group, and region.

Depending upon the modality, the global business is categorized into arteriovenous, venoarteial, and venovenous. In terms of application, the worldwide industry is categorized into extracorporeal cardiopulmonary resuscitation, cardiac, and respiratory. Based on the age group, the target market is segmented into neonatal, pediatric, and adults.

Regional Insights:

Regionally, the overall industry is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America extracorporeal membrane oxygenation machine market is at the forefront, due to the presence of major players and repeated product launches. In addition, increasing prevalence of diseases such as chronic obstructive pulmonary disease (COPD) in the U.S and high purchasing power parity of patients are driving growth of the market in this region. Furthermore, government support for quality healthcare, sophisticated healthcare facilities and favorable reimbursement policies has propelled the usage rate of ECMO machines. Whereas, the Asia Pacific extracorporeal membrane oxygenation machines market is projected to register the fastest growth in the upcoming years, owing to increasing healthcare expenditure by private and government agencies in order to improve healthcare facilities. Along with this, economic development in countries such as India, Japan, and China are creating growth opportunities for the market.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029.  For the purpose of this study, has segmented the global extracorporeal membrane oxygenation (ECMO) system market report based on modality, application, age group, and region.

Global Extracorporeal Membrane Oxygenation (ECMO) System Market, By Modality:

• Arteriovenous
• Venoarteial
• Venovenous

Global Extracorporeal Membrane Oxygenation (ECMO) System Market, By Application:

• Extracorporeal cardiopulmonary resuscitation
• Cardiac
• Respiratory

Global Extracorporeal Membrane Oxygenation (ECMO) System Market, By Age Group:

• Neonatal
• Pediatric
• Adults

Global Extracorporeal Membrane Oxygenation (ECMO) System Market, By Region:

• • • North America
      • • U.S.
        • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The key players operating in the global extracorporeal membrane oxygenation (ECMO) system market include Getinge Group, Medtronic plc, LivaNova PLC, ALung Technologies, Inc., XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, OriGen Biomedical, Inc., NIPRO Corporation, and EUROSETS S.r.l. Companies are increasing their investments in R&D to expand its product portfolio and market presence. In April 2019, Hemovent GmbH announced that its next generation ECMO system, MOBYBOX, has been validated in a pilot in vivo study by Minnesota Resuscitation Consortium, which is designing a ‘super ambulance’ that will beequipped with the latest technology to advance treatment of cardiac-arrest emergency patients.

• Getinge Group
  • Company Overview
  • Modality Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies

• Medtronic plc
• LivaNova PLC
• ALung Technologies, Inc.
• XENIOS AG
• Terumo Corporation
• MicroPort Scientific Corporation
• OriGen Biomedical, Inc.
• NIPRO Corporation
• EUROSETS S.r.l.

 “*” marked represents similar segmentation in other categories in the respective section